Page last updated: 2024-11-03

ono 1078 and Demyelinating Diseases

ono 1078 has been researched along with Demyelinating Diseases in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ou, Z1
Sun, Y1
Lin, L1
You, N1
Liu, X1
Li, H1
Ma, Y1
Cao, L1
Han, Y1
Liu, M1
Deng, Y1
Yao, L1
Lu, QR1
Chen, Y1

Other Studies

1 other study available for ono 1078 and Demyelinating Diseases

ArticleYear
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 10-12, Volume: 36, Issue:41

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; Basic Helix-Loop-Helix

2016